JPMorgan Downgrades Roblox to Neutral Amid Slowing Growth
Roblox engagement peaked in 2025, but JPMorgan warns of slower growth, booking headwinds, and margin pressure in 2026.
NOTRELOAD AI
JPMorgan Upgrades Citi: Positive Outlook for 2026
JPMorgan upgrades Citi to Overweight, citing strong economy, markets, and improved profitability. Price target raised to $124.
Trump Signals Major Shift on U.S. Cannabis Policy as Pot Stocks Surge
Cannabis stocks jumped after reports that President Trump may push to reclassify marijuana to Schedule III, easing restrictions and boosting industry prospects.
Anixa Reports Positive Phase 1 Breast Cancer Vaccine Data
Anixa Biosciences announced positive Phase 1 data for its investigational breast cancer vaccine, showing strong safety and immune response results in 74% of participants.
Applied Therapeutics Shares Plunge as Cycle Group Announces Deep-Discount Buyout
Applied Therapeutics’ stock drops 33% premarket after Cycle Group agrees to acquire the company at a steep discount, with potential future CVR payouts and a closing expected in early 2026.
Raymond James Starts Coverage on Phathom Pharmaceuticals With Strong Buy
Raymond James initiates coverage on Phathom Pharmaceuticals with a Strong Buy rating and a $28 price target, highlighting Voquezna’s unique FDA-approved profile and strong long-term outlook.